Canadian ground beef processors and retailers are requesting authorities not to flag their products under a health warning label law against food and beverages with over 15 percent of the recommended daily allowance for saturated fat, salt, or sugar per serving.
In a few weeks, regulations for the health nutrition warning labels are expected to be released by Health Canada, the agency in charge of government health initiatives.
Certain dairy products and whole-muscle meats will be exempt from the ban on certain food categories. Ground beef processors and retailers are attempting to have that excluded as well, arguing that their fat content is already regulated and stated on the packaging.
The meat industry and a few conservative lawmakers have pushed for a complete postponement of the warning system's implementation. But proponents point out that since 2016, Health Canada has been having conversations about it.


Why the future of marijuana legalization remains hazy despite high public support
Trump and IRS in Settlement Talks Over $10 Billion Tax Return Leak Lawsuit
Judge Delays SEC Settlement With Elon Musk Over Twitter Stock Disclosure Case
Judge Rules DOGE Humanities Grant Cuts Unconstitutional
TikTok Nears $400 Million Settlement With Trump Administration Over Child Privacy Lawsuit
Judge Rules Use of Military Lawyers in Civilian Prosecutions Is Lawful
AcadeMedia Q3 Profit Climbs as International and Adult Education Segments Drive Growth
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
DOJ Ends Probe Into Fed Chair Jerome Powell, Boosting Kevin Warsh Confirmation Prospects
Dell Stock Hits Record High After Trump Endorsement, AI Server Demand Fuels Rally
US, Japan Reaffirm Strong Currency Coordination Amid Yen Volatility
KOSPI Hits Record High as AI Chip Demand Boosts Samsung and SK Hynix
Gold Prices Hold Firm as Traders Watch U.S.-Iran Ceasefire and Trump-Xi Talks
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
ECB Signals Possible Interest Rate Move if Inflation Outlook Fails to Improve 



